In breast cancer cells, MAP3K1 activates MEK1/2 indirectly by stimulating an MAP2K4/MAP2K7→JNK pathway, which results in JNK-mediated positive feedback activation of ERBB RTKs that activate MEK1/235. This evidence concerns the gene MAP2K1 and breast carcinoma.